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~ Perception of shortness of breath and disability living allowance 
in adult Cystic Fibrosis 
S. Bari, A. Morris, D.A. Stock, M.J. Ledson, M.J. Walshaw. Adult Regional 
CF Unit, The Cardiothoracic Centre, Liverpool, UK 
Introduction: CF patients with severe disease are often limited in their ex- 
ercise tolerance, and in the UK may benefit from the State Disability Living 
Allowance (DLA). The criteria for the mobility component of this include a virtual 
inability to walk, or that the exertion required would endanger life. This may not 
be appropriate for CF patients. To look at this further, we tested the ability to walk 
and the perception of breathlessness in a group of adult CF patients. 
Method: 26 stable patients, (all receiving the mobility DLA benefit, mean age 
24 years [range 18 42], 11 male) exercised on a treadmill: pulse oximetry, 
maximum walking time and speed were recorded, as was breathlessness at exercise 
cessation using the BORG 10 point scale. 
Results: Average walking time was 22.5 minutes [range 2 30] at an average speed 
of 3.7mph [1.5 6.5]. Only 2 patients walked <6 minutes (1 LTOT, 1 BIPAP). As 
regards breathlessness on exercise cessation, 7 patients (27%) had a BORG score of 
2, 14 (54%) 3, 4 (16%) 4 and 1 (3%) 6, (overall mean 3). There was no correlation 
between BORG score and walking speed, but a significant relationship between 
BORG score and walking time (r 0.64, p < 0.001), and BORG score and oxygen 
saturation at exercise cessation (r 0.58, p < 0.01). 
Conclusion: In this group perception of breathlessness depends on the length of 
the time walked rather than the speed of walking, and was also related to oxygen 
saturation. Although most patients could walk more than six minutes, all are on 
the highest level of DLA and all receive mobility allowance for clinical reasons. 
This work suggests that the usual qualifying tests for DLA are not appropriate 
for CF patients and this should be borne in mind when encouraging those with 
advanced isease to apply for this benefit. 
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1~ Determinants of dyspnoea in Cystic Fibrosis: impact of 
inspiratory muscles endurance 
S. Leroy, T. Perez, R. Nevi~re, B. Wallaert. Clinique des' maladies' respiratoires, 
H@ital Calmette, CHRU de Lille, France 
Dyspnoea is one of the main complain of patients with cystic fibrosis (CF). 
Lung function at rest is not sufficient o explain dyspnoea during exercise. Little 
information is available about the impact of respiratory muscle endurance. 
Methods: Inspiratory muscle endurance (IME), expressed as a percentage of 
maximal inspiratory pressure (PImax), was measured according to an incremental 
threshold loading technique (Martyn) in eighteen stable CF patients. All of them 
performed a maximal exercise testing on a cycloergometer. Level of dyspnoea was 
recorded by Borg scale at exhaustion. Blood gases were analysed at rest and at 
maximal exercising. 
Results: Four men and fourteen women were included with a mean age of 32 years 
(20 67). Mean FEV1 was 44% pred (21 82%). Mean PImax was 78% pred (24 
148). No significant correlations were found between dyspnoea nd age, body 
mass index, pulmonary function at rest, blood gases, inspiratory muscle strength 
(PImax) or exercise capacity. Dyspnoea was only correlated with inspiratory muscle 
endurance (r 0.69, p 0.0015) and plethysmographic a rway resistance (r 0.53, 
p 0.018). When patients were grouped according to their inspiratory muscle 
endurance, ten patients had normal values and eight showed a decreased IME. 
Significant differences were observed between these two groups in dyspnoea (4.6 
versus 7.6; p<0.001), PaCO 2 at rest (36.4 versus 40.7mmHg; p 0.017) and at 
peak exercise (41 versus 48 mmHg; p 0.033). 
Conclusion: If inspiratory muscle function may be relatively preserved in chronic 
lung disease due to a training effect, it may be a significant a determinant of 
dyspnoea nd hypoventilation during exercise in CF patients. 
• Relationship between breathlessness and exercise in adult 
CF patients 
S. Bari, A. Morris, M.J. Ledson, M.J. Walshaw. Regional Adult CF Unit, The 
Cardiothoracic Centre, Liverpool, UK 
Introduction: Exercise capability is an integral part of the assessment of physical 
wellbeing in adult CF patients. However, the relationship between this, pulmonary 
function, oxygen saturation (OS) during exercise and the perception of breathless- 
ness in this group is poorly understood. To investigate this, we looked at these 
parameters in CF adults undergoing a 6 minute walk test. 
Methods: Following spirometry, all were exercised on a treadmill: 6minute walking 
distance (6MWD) was measured and then the speed increased incrementally every 3 
minutes until maximum time (TMax) and maximum sustainable speed (MSS) were 
reached. Minimum oxygen saturation (MOS) and breathlessness (BORG score) were 
recorded. Physical activity was assessed by calculating the metabolic equivalent 
(MET). 
Results: 24 patients (mean age 23 [range18 33], mean FEV1 56% predicted [23 
114], 10 male) were studied: mean 6MWD distance 572 metres [318 1046], TMax 
24 minutes [6 30], MSS 3.5 mph [2 6.5], MOS 95% [91 97], BORG score 3 [2 4] 
and MET 4.3 [2.5 11]. Although spirometry correlated significantly with 6MWD 
(P 0.004), MSS (P 0.012), and MOS (P 0.004), there was no correlation with 
TMax (P 0.85) or BORG score (P 0.13). Moreover, there was no correlation 
between breathlessness and the amount of physical activity achieved (P 0.25), nor 
between MOS and energy spent as measured by MET (P 0.38). 
Conclusion: In adult CF patients, the relationship between breathlessness and the 
objective measures of exercise (pulmonary function, exercise capability, energy 
consumption and oxygen saturation during exercise) is complex. We have found 
that breathlessness cores do not depend on pulmonary function, nor do they 
reflect metabolic activity. Further work is necessary to elucidate the causes of 
breathlessness in this patient group. 
1• Working capacity and lung function in physically active patients 
with Cystic Fibrosis were unchanged after 6 months of training 
M. Sahlberg, B. Strandvik, B.O. Eriksson. Dept of Paediatrics, Institute of Clinical 
Sciences, Sahlgrenska Academy, GOteborg University, Sweden 
The aim was to investigate if cardiopulmonary functions improved uring 6 m of 
different types of training in adult patients with CF despite no increase in muscular 
strength. 
Methods: Twenty patients (8 females (F)) with classical CF accepted to participate 
in a study with endurance and/or strength training three times/week for 6 m. The 
intensity of endurance training was at 70 75% of achieved heart rate (HR) at 
VO2max, tested on an electronically braked ergometer cycle. Strength training was 
performed with free weights or individuals own body as load and with increasing 
load. Twenty healthy subjects matched for age, sex, anthropometry and physical 
activity were controls. Lung function and working capacity (WC) were measured 
at baseline, and after 3 and 6 months. 
Results: Mean (SD) FEV1 in CF F vs controls was 2.8 (0.6) litre and 3.6 (0.5) 1 
(p 0.05) and in males (M) 4.0 (1.1) 1 vs 4.7 (0.5) 1 (NS), FEV1% of predicted 
were 90 (19) vs 114 (10) (p 0.01) and 92 (22) vs 107 (10) (p 0.04), respectively, 
and did not decrease during the 6 months. At baseline WC was significantly lower 
in CF compared to controls, in F 170 (31) vs 205 (26) watt (p 0.04) and in M 
273 (54) vs 319 (47) watt (p 0.03), but not per kg body weight. HR and VO 2 max in 
ml/kg × rain were at baseline not significantly different from controls, but VO2max 
in 1/min tended to be lower in CF, in F 1.9 (0.6) vs 2.4 (0.3) (p 0.05) and in M 
3.1 (0.6) vs 3.5 (0.5) 1/min (p 0.06). WC, HR and VO2max did not change during 
the 6 months of training. WC and VO2max were significantly correlated to FEV1 
in patients and controls. 
Conclusion: The absence of improvement in muscular strength was not due to 
impairment in cardiac or pulmonary function. 
